Muscle DamageNCT01555775
Compared Effect of a Fruit Milk Shake With a Protein-Carbohydrate Supplement on Recovery After Resistance Exercise
A study testing P-CHO supplement and Fruit Milk Shake in people with Muscle Damage and Inflammation, run by Universidade do Porto at 1 site in Portugal.
Trial summary
The aim of this study is to assess the effect of ingesting a commercial carbohydrate and protein dietary supplement in powder form (P-CHO supplement) or a milk shake with skimmed milk, strawberries and banana (MS), after resistance exercise, in muscle damage, oxidative stress, inflammation and functional recovery. Read more about this study
- Who is it for?
- Ages 18 years and older, men onlyHealthy volunteers can take part
- Conditions the study is for
- Muscle Damage, Inflammation, Oxidative Stress
- What is being tested?
- P-CHO supplement and Fruit Milk Shake
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 13 participants
- Where
- 1 sitePortugal
- Study dates
- Mar 2012to May 2012
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Men only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- healthy and lactose tolerant
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Compared Effect of a Fruit Milk Shake With a Protein-Carbohydrate Supplement on Muscle Damage, Inflammation, Oxidative Stress and Functional Recovery, After Resistance Exercise
The aim of this study is to assess the effect of ingesting a commercial carbohydrate and protein dietary supplement in powder form (P-CHO supplement) or a milk shake with skimmed milk, strawberries and banana (MS), after resistance exercise, in muscle damage, oxidative stress, inflammation and functional recovery. It is hypothesised if the ingestion of a milk shake with skimmed milk and fruit (strawberry and banana) has the same impact on markers of muscle damage, oxidative stress, inflammation and functional recovery induced by resistance exercise, as the intake of a commercial powder with the same CHO and protein amounts.
Fifteen adult athletes from the Portuguese Athletic Federation will complete 2 trials separated at least by 2 weeks. Alternate legs and drinks will be used in each trial and participants will be overnight-fasted. This study will have a single-blind, randomized, crossover, repeated-measures experimental design. In each trial, after warm-up, the eccentric peak torque of the knee joint extensors will be determined using an isokinetic dynamometer. After this, participants will complete an isokinetic exercise until exhaustion at a constant angular velocity of 60° • s-1. After the exhaustion protocol, athletes will perform again the peak torque determination. Immediately after, participants will drink the P-CHO supplement or MS during the first 2 h. Both drinks will contain 0.8-1.2 g carbohydrates • kg-1 • h-1 and 0.2-0.4 g protein • kg-1 • h-1. Twenty four and 48 h after the exhaustion protocol participants will return to the laboratory to repeat the peak torque determination. Blood samples will be collected before warming-up, immediately and 2 h after the last peak torque determination and 24 h and 48 h after. Serum samples will be analyzed for creatine kinase, lactate dehydrogenase, interleukine-6, protein carbonyls and total antioxidant status. The delayed onset muscle soreness, using a visual analogue scale, and girths will be measured at the same moments as blood sampling. Two-way repeated-measures ANOVA will be used for statistical analysis of the data.
Read the detailed description
Sample:
Fifteen adult athletes from the Portuguese Athletic Federation will be invited to participate in this study. They must be healthy and lactose tolerant. Athletes will be voluntary and should receive an explanatory document with the aims of the study. They must also sign an informed consent to participate. To help ensuring that the metabolic conditions are similar between trials, subjects will be instructed to fulfill a food record and a physical activity record of the 2 days prior to each trial (Shirreffs, Watson, \& Maughan, 2007). It will be asked not to make drastic changes in diet and to avoid strenuous exercise during this period.
Experimental Protocol:
This study will have a single-blind, randomized, crossover, repeated-measures experimental design. As shown in Figure 1, each participant should complete 2 trials, with a wash out period of, at least, 2 weeks. In one trial subjects will randomly drink the P-CHO supplement and in the other, the MS. In order to minimize any repeated bout effect, different legs will be used in each trial (Howatson et al., 2010).
About one week before the exercise protocol, participants will be familiarized with the experimental procedures and measurements. At this time, anthropometric assessments (BW, height and body fat percentage) will also be taken.
All tests should be performed in the morning, in a fasted state. At the beginning of each trial, the participants will warm-up for 5 min using a cycle ergometer at an intensity of 70-100 rpm. After the warm-up, the eccentric peak torque of the knee joint extensors muscles will be determined by isokinetic dynamometry (Biodex®, system IV). Then, the participants will complete concentric/eccentric knee extension/flexion exercise protocol until exhaustion. After exhaustion, eccentric peak torque determination will be repeated. Immediately after finishing the isokinetic test, participants will drink the P-CHO supplement or MS during the first 2 hours post-exercise. The drinks will be taken in 2 bolus per hour, during 2 h. During the 2 days after the exhaustion protocol (24 h and 48 h after), participants will return to the laboratory to repeat eccentric peak torque determination after a similar warm-up of the day before.
Drinks' Composition:
The nutritional formula of both drinks will be equal in terms of CHO and protein content in order to achieve the recommendation values of 0.8-1.2 g CHO • kg-1 BW • h-1 and 0.2-0.4 g protein • kg-1 BW • h-1 (Beelen et al 2010). They will also have similar amounts of vitamin C.
The fruit content of the MS will be 100 g of strawberry and the amount of banana necessary to guaranty 0.8-1.2 g CHO • kg-1 BW • h-1. Regarding the P-CHO supplement, it has to be available in a common local market and meet the recommend amounts of CHO and protein for the recovery period. If necessary, vitamin C will be added to match the MS content.
Exhaustion Protocol:
For inducting exhaustion, a concentric/eccentric knee extension/flexion exercise until exhaustion will be used. At the first day of each trial, the exhaustion protocol will be conducted. Securely fastened into the test chair of the isokinetic dynamometer with the knee joint of the test limb aligned with the axis of rotation of the dynamometer and the distal lower limb secured to the dynamometer's test arm, subjects will initially complete 3 maximal repetitions of knee joint extension and flexion at a constant angular velocity of 60°•s-1 to determine the subject's maximal peak torque of the knee extensors muscles (the best of the 3 repetitions). After this, the exhaustion protocol it will be conducted. The protocol will consist of 3 bouts of a concentric/eccentric knee extension/flexion exercise, at 60°•s-1, with a 200-second rest time between sets. The first and second set will be composed by 100 repetitions; in the third set, subjects will perform n repetitions until the eccentric peak value of 3 consecutive repetitions fell below 25% of the initial knee extensor eccentric peak torque value. The range of motion will be from 50° to 110° flexion in the knee (0º = full knee extension).
Participants will receive verbal encouragement to perform maximally throughout the exercise protocol.
Functional Recovery:
To monitor force recovery, measures of eccentric peak torque of the knee joint extensor muscles will be determined. Athletes will perform the isokinetic strength tests immediately before and after the exhaustion protocol and 24 and 48 h after the exhaustion protocol, for each trial. The exercise will consist of 3 maximal repetitions to determine eccentric knee joint extension peak torque at a constant angular velocity of 60°•s-1. The range of motion will be similar to the one used in the exhaustion protocol.
Blood Sampling and Biomarkers:
For each trial, blood will be taken from an antecubital vein after the participant arrives at the laboratory, in a fasted state. Blood samples will also be collected immediately after the last peak torque determination and 2, 24 and 48 h after.
The following blood markers will be used:
- Muscle damage: CK and LDH;
- Inflammation: IL-6;
- Oxidative stress: protein carbonyls and TAS.
Other Measurements:
The DOMS and circumferential measurements will be measured at the same moments as blood sampling.
A visual analogue scale (VAS), 10 cm in length, will be used to determine DOMS (Bijur, Silver, \& Gallagher, 2001).
The mid-thigh girth measurement will be done according to the anthropometric technique suggested by the International Society for the Advancement of Kinanthropometry (ISAK). Three other girths will be measured: 5, 15 and 25 cm above the superior border of the patella. These measurements will allow monitoring the oedema caused by inflammation.
Body Composition:
Weight and height will be measured according to the methodology proposed by the International Society for the ISAK. It will be calculated the body mass index (BMI) and the percentage of body fat by measuring four skinfolds (biceps, triceps, subscapular and suprailiac) according to the technique proposed by ISAK. The value of the measurements will be converted to body density and using the formula: Durnin and Womersley 1974 (Costa, 2001). Later, the body density value will be converted to percentage of body mass, using the formula of Siri (Costa, 2001).
Dietary Intake:
Athletes will be asked to carry out food records 2 days prior to each trial. Each individual will be informed both orally and in writing, by an expert nutritionist, on their correct completion. It also will be required to register the time and place where food consumption was made. Subsequently, data will be processed through a computer program (Food Processor®) to convert the information into energy and nutrients and calculate mean intakes.
Physical Activity:
Two days prior to each trial, athletes will record the type, intensity and duration of physical activities in registration documents distributed previously.
Statistical Analysis:
Statistical analysis will be performed using the Statistical Package for Social Sciences (SPSS 18 for Windows TM®). The results will be expressed as mean ± standard deviation and it will be considered a statistically significant for p < 0.05. Normality will be assessed by the Kolmogorov-Smirnov test. Data will be analyzed by two-way repeated-measures ANOVA (treatment [two levels: MS and P-CHO supplement] vs time [five levels]) to determine whether there are any statistically significant effects of time or treatment (Bowtell, Sumners, Dyer, Fox, \& Mileva, 2011). The Mauchly sphericity test will be used to check homogeneity of covariance for all ANOVA analyses; violations of the assumption of sphericity will be correct using the Greenhouse-Geisser adjustment. Where appropriate, the effect size (ƞ2) will also be calculated.
- Conditions
- Muscle Damage, Inflammation, Oxidative Stress, Functional Recovery
- Being tested
- P-CHO supplement, Fruit Milk Shake
- Keywords
- exercise-induced muscle damage, nutritional recovery, nutritional supplement, natural food
- Medical subject headings
- Inflammation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
P-CHO supplementDietary supplement
Also called Available in a common local market.
In the first trial, this group will drink a protein (P)-carbohydrate (CHO) supplement and in the second trial the fruit milk shake.
Fruit Milk ShakeDietary supplement
Also called Strawberry, bananas, skimmed milk
The fruit content of the milk shake will be 100 g of strawberry and the amount of banana necessary to guaranty 0.8-1.2 g CHO • kg-1 BW • h-1.
| Study group | Role | What they receive |
|---|---|---|
| P-CHO supplement | Experimental | This group will drink the P-CHO supplement in the first trial and the fruit milk shake in the second. Receives: Dietary Supplement: P-CHO supplement |
| Fruit Milk Sake | Experimental | This group will drink the fruit milk shake in the first trial and the P-CHO supplement in the second. Receives: Dietary Supplement: Fruit Milk Shake |
What is being measured
The primary outcome is the main question the study is designed to answer.
Maximal peak torque of the knee extensors muscles
To monitor functional recovery
Measured: Up to 48 h
Creatine kinase
To monitor muscle damage
Measured: Up to 48 h
Lactate dehydrogenase
To monitor muscle damage
Measured: Up to 48 h
Interleukine-6
To monitor the inflammatory process
Measured: Up to 48 h
Total antioxidant status
To monitor oxidative stress
Measured: Up to 48 h
Delayed onset muscle soreness
By a visual analogue scale, 10 cm in length. To monitor muscle soreness
Measured: Up to 48 h
Mid-thigh girth, Three other girths will be measured: 5, 15 and 25 cm above the superior border of the patella.
To monitor the inflammatory process
Measured: Up to 48 h
Protein carbonyls
To monitor oxidative stress
Measured: Up to 48 h
Secondary outcomes (3)
Percentage of body fat
Measured: 1 week before the first trial
Food records
To assess energy intake (kcal)
Measured: 2 days before each trial
Physical activity records
To assess energy expenditure (kcal)
Measured: 2 days before each trial
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Mar 2012 (estimated)
- Study startMar 2012
- Primary completionMar 2012
- Study completionMay 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (44)Papers the sponsor has linked to this study.
- Other trials for Muscle DamageStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 13 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidade do Porto
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Monica Sousa, Principal Investigator, Universidade do Porto
- Investigators
- José Soares, PhD, Study director, Faculdade de Desporto, Universidade do PortoMonica V. Sousa, BSc, Principal investigator, Faculdade de Desporto, Universidade do PortoVitor H Teixeira, PhD, Study chair, Faculdade de Ciências da Nutrição e Alimentação, Universidade do Porto
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01555775
- Sponsor's protocol ID
- SFRH/BD/75276/2010
- Status last verified
- Jan 2013
- First submitted
- 7 Mar 2012
- Last updated
- 16 Jan 2013
- Results posted
- No
- Data monitoring committee
- No
Publications
Banerjee AK, Mandal A, Chanda D, Chakraborti S. Oxidant, antioxidant and physical exercise. Mol Cell Biochem. 2003 Nov;253(1-2):307-12. doi: 10.1023/a:1026032404105.
PubMed 14619981Battino M, Mezzetti B. Update on fruit antioxidant capacity: a key tool for Mediterranean diet. Public Health Nutr. 2006 Dec;9(8A):1099-103. doi: 10.1017/S1368980007668554.
PubMed 17378947Beelen M, Burke LM, Gibala MJ, van Loon L JC. Nutritional strategies to promote postexercise recovery. Int J Sport Nutr Exerc Metab. 2010 Dec;20(6):515-32. doi: 10.1123/ijsnem.20.6.515.
PubMed 21116024Ben-Amotz A, Levy Y. Bioavailability of a natural isomer mixture compared with synthetic all-trans beta-carotene in human serum. Am J Clin Nutr. 1996 May;63(5):729-34. doi: 10.1093/ajcn/63.5.729.
PubMed 8615356Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med. 2001 Dec;8(12):1153-7. doi: 10.1111/j.1553-2712.2001.tb01132.x.
PubMed 11733293Bos C, Metges CC, Gaudichon C, Petzke KJ, Pueyo ME, Morens C, Everwand J, Benamouzig R, Tome D. Postprandial kinetics of dietary amino acids are the main determinant of their metabolism after soy or milk protein ingestion in humans. J Nutr. 2003 May;133(5):1308-15. doi: 10.1093/jn/133.5.1308.
PubMed 12730415Bowtell JL, Sumners DP, Dyer A, Fox P, Mileva KN. Montmorency cherry juice reduces muscle damage caused by intensive strength exercise. Med Sci Sports Exerc. 2011 Aug;43(8):1544-51. doi: 10.1249/MSS.0b013e31820e5adc.
PubMed 21233776Brancaccio P, Lippi G, Maffulli N. Biochemical markers of muscular damage. Clin Chem Lab Med. 2010 Jun;48(6):757-67. doi: 10.1515/CCLM.2010.179.
PubMed 20518645Burke LM, Castell LM, Stear SJ. BJSM reviews: A-Z of supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 1. Br J Sports Med. 2009 Oct;43(10):728-9. doi: 10.1136/bjsm.2009.063941. No abstract available.
PubMed 19808984Burke LM, Castell LM, Stear SJ, Rogers PJ, Blomstrand E, Gurr S, Mitchell N, Stephens FB, Greenhaff PL. BJSM reviews: A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 4. Br J Sports Med. 2009 Dec;43(14):1088-90. doi: 10.1136/bjsm.2009.068643. No abstract available.
PubMed 19955167Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem. 1998 Jun;44(6 Pt 1):1309-15.
PubMed 9625058Cheung K, Hume P, Maxwell L. Delayed onset muscle soreness : treatment strategies and performance factors. Sports Med. 2003;33(2):145-64. doi: 10.2165/00007256-200333020-00005.
PubMed 12617692Close GL, Ashton T, McArdle A, Maclaren DP. The emerging role of free radicals in delayed onset muscle soreness and contraction-induced muscle injury. Comp Biochem Physiol A Mol Integr Physiol. 2005 Nov;142(3):257-66. doi: 10.1016/j.cbpa.2005.08.005. Epub 2005 Sep 8.
PubMed 16153865Ebbeling CB, Clarkson PM. Exercise-induced muscle damage and adaptation. Sports Med. 1989 Apr;7(4):207-34. doi: 10.2165/00007256-198907040-00001.
PubMed 2657962Ehlenfeldt MK, Prior RL. Oxygen radical absorbance capacity (ORAC) and phenolic and anthocyanin concentrations in fruit and leaf tissues of highbush blueberry. J Agric Food Chem. 2001 May;49(5):2222-7. doi: 10.1021/jf0013656.
PubMed 11368580
Study at a glance
From the registry record, last updated by the sponsor on 16 Jan 2013. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Compared Effect of a Fruit Milk Shake With a Protein-Carbohydrate Supplement on Muscle Damage, Inflammation, Oxidative Stress and Functional Recovery, After Resistance Exercise
- ClinicalTrials.gov ID
- NCT01555775
- Acronym / sponsor ID
- SFRH/BD/75276/2010
- Conditions
- Muscle Damage, Inflammation, Oxidative Stress, Functional Recovery
- Keywords
- exercise-induced muscle damage, nutritional recovery, nutritional supplement, natural food
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 13 participants (actual)
- Lead sponsor
- Universidade do PortoUniversity, hospital or other
- Study start
- Mar 2012
- Primary completion
- Mar 2012 (actual)
- Study completion
- May 2012 (actual)
- First posted
- 15 Mar 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to assess the effect of ingesting a commercial carbohydrate and protein dietary supplement in powder form (P-CHO supplement) or a milk shake with skimmed milk, strawberries and banana (MS), after resistance exercise, in muscle damage, oxidative stress, inflammation and functional recovery. It is hypothesised if the ingestion of a milk shake with skimmed milk and fruit (strawberry and banana) has the same impact on markers of muscle damage, oxidative stress, inflammation and functional recovery induced by resistance exercise, as the intake of a commercial powder with the same CHO and protein amounts.
Fifteen adult athletes from the Portuguese Athletic Federation will complete 2 trials separated at least by 2 weeks. Alternate legs and drinks will be used in each trial and participants will be overnight-fasted. This study will have a single-blind, randomized, crossover, repeated-measures experimental design. In each trial, after warm-up, the eccentric peak torque of the knee joint extensors will be determined using an isokinetic dynamometer. After this, participants will complete an isokinetic exercise until exhaustion at a constant angular velocity of 60° • s-1. After the exhaustion protocol, athletes will perform again the peak torque determination. Immediately after, participants will drink the P-CHO supplement or MS during the first 2 h. Both drinks will contain 0.8-1.2 g carbohydrates • kg-1 • h-1 and 0.2-0.4 g protein • kg-1 • h-1. Twenty four and 48 h after the exhaustion protocol participants will return to the laboratory to repeat the peak torque determination. Blood samples will be collected before warming-up, immediately and 2 h after the last peak torque determination and 24 h and 48 h after. Serum samples will be analyzed for creatine kinase, lactate dehydrogenase, interleukine-6, protein carbonyls and total antioxidant status. The delayed onset muscle soreness, using a visual analogue scale, and girths will be measured at the same moments as blood sampling. Two-way repeated-measures ANOVA will be used for statistical analysis of the data.
Detailed description
Sample:
Fifteen adult athletes from the Portuguese Athletic Federation will be invited to participate in this study. They must be healthy and lactose tolerant. Athletes will be voluntary and should receive an explanatory document with the aims of the study. They must also sign an informed consent to participate. To help ensuring that the metabolic conditions are similar between trials, subjects will be instructed to fulfill a food record and a physical activity record of the 2 days prior to each trial (Shirreffs, Watson, \& Maughan, 2007). It will be asked not to make drastic changes in diet and to avoid strenuous exercise during this period.
Experimental Protocol:
This study will have a single-blind, randomized, crossover, repeated-measures experimental design. As shown in Figure 1, each participant should complete 2 trials, with a wash out period of, at least, 2 weeks. In one trial subjects will randomly drink the P-CHO supplement and in the other, the MS. In order to minimize any repeated bout effect, different legs will be used in each trial (Howatson et al., 2010).
About one week before the exercise protocol, participants will be familiarized with the experimental procedures and measurements. At this time, anthropometric assessments (BW, height and body fat percentage) will also be taken.
All tests should be performed in the morning, in a fasted state. At the beginning of each trial, the participants will warm-up for 5 min using a cycle ergometer at an intensity of 70-100 rpm. After the warm-up, the eccentric peak torque of the knee joint extensors muscles will be determined by isokinetic dynamometry (Biodex®, system IV). Then, the participants will complete concentric/eccentric knee extension/flexion exercise protocol until exhaustion. After exhaustion, eccentric peak torque determination will be repeated. Immediately after finishing the isokinetic test, participants will drink the P-CHO supplement or MS during the first 2 hours post-exercise. The drinks will be taken in 2 bolus per hour, during 2 h. During the 2 days after the exhaustion protocol (24 h and 48 h after), participants will return to the laboratory to repeat eccentric peak torque determination after a similar warm-up of the day before.
Drinks' Composition:
The nutritional formula of both drinks will be equal in terms of CHO and protein content in order to achieve the recommendation values of 0.8-1.2 g CHO • kg-1 BW • h-1 and 0.2-0.4 g protein • kg-1 BW • h-1 (Beelen et al 2010). They will also have similar amounts of vitamin C.
The fruit content of the MS will be 100 g of strawberry and the amount of banana necessary to guaranty 0.8-1.2 g CHO • kg-1 BW • h-1. Regarding the P-CHO supplement, it has to be available in a common local market and meet the recommend amounts of CHO and protein for the recovery period. If necessary, vitamin C will be added to match the MS content.
Exhaustion Protocol:
For inducting exhaustion, a concentric/eccentric knee extension/flexion exercise until exhaustion will be used. At the first day of each trial, the exhaustion protocol will be conducted. Securely fastened into the test chair of the isokinetic dynamometer with the knee joint of the test limb aligned with the axis of rotation of the dynamometer and the distal lower limb secured to the dynamometer's test arm, subjects will initially complete 3 maximal repetitions of knee joint extension and flexion at a constant angular velocity of 60°•s-1 to determine the subject's maximal peak torque of the knee extensors muscles (the best of the 3 repetitions). After this, the exhaustion protocol it will be conducted. The protocol will consist of 3 bouts of a concentric/eccentric knee extension/flexion exercise, at 60°•s-1, with a 200-second rest time between sets. The first and second set will be composed by 100 repetitions; in the third set, subjects will perform n repetitions until the eccentric peak value of 3 consecutive repetitions fell below 25% of the initial knee extensor eccentric peak torque value. The range of motion will be from 50° to 110° flexion in the knee (0º = full knee extension).
Participants will receive verbal encouragement to perform maximally throughout the exercise protocol.
Functional Recovery:
To monitor force recovery, measures of eccentric peak torque of the knee joint extensor muscles will be determined. Athletes will perform the isokinetic strength tests immediately before and after the exhaustion protocol and 24 and 48 h after the exhaustion protocol, for each trial. The exercise will consist of 3 maximal repetitions to determine eccentric knee joint extension peak torque at a constant angular velocity of 60°•s-1. The range of motion will be similar to the one used in the exhaustion protocol.
Blood Sampling and Biomarkers:
For each trial, blood will be taken from an antecubital vein after the participant arrives at the laboratory, in a fasted state. Blood samples will also be collected immediately after the last peak torque determination and 2, 24 and 48 h after.
The following blood markers will be used:
- Muscle damage: CK and LDH;
- Inflammation: IL-6;
- Oxidative stress: protein carbonyls and TAS.
Other Measurements:
The DOMS and circumferential measurements will be measured at the same moments as blood sampling.
A visual analogue scale (VAS), 10 cm in length, will be used to determine DOMS (Bijur, Silver, \& Gallagher, 2001).
The mid-thigh girth measurement will be done according to the anthropometric technique suggested by the International Society for the Advancement of Kinanthropometry (ISAK). Three other girths will be measured: 5, 15 and 25 cm above the superior border of the patella. These measurements will allow monitoring the oedema caused by inflammation.
Body Composition:
Weight and height will be measured according to the methodology proposed by the International Society for the ISAK. It will be calculated the body mass index (BMI) and the percentage of body fat by measuring four skinfolds (biceps, triceps, subscapular and suprailiac) according to the technique proposed by ISAK. The value of the measurements will be converted to body density and using the formula: Durnin and Womersley 1974 (Costa, 2001). Later, the body density value will be converted to percentage of body mass, using the formula of Siri (Costa, 2001).
Dietary Intake:
Athletes will be asked to carry out food records 2 days prior to each trial. Each individual will be informed both orally and in writing, by an expert nutritionist, on their correct completion. It also will be required to register the time and place where food consumption was made. Subsequently, data will be processed through a computer program (Food Processor®) to convert the information into energy and nutrients and calculate mean intakes.
Physical Activity:
Two days prior to each trial, athletes will record the type, intensity and duration of physical activities in registration documents distributed previously.
Statistical Analysis:
Statistical analysis will be performed using the Statistical Package for Social Sciences (SPSS 18 for Windows TM®). The results will be expressed as mean ± standard deviation and it will be considered a statistically significant for p < 0.05. Normality will be assessed by the Kolmogorov-Smirnov test. Data will be analyzed by two-way repeated-measures ANOVA (treatment [two levels: MS and P-CHO supplement] vs time [five levels]) to determine whether there are any statistically significant effects of time or treatment (Bowtell, Sumners, Dyer, Fox, \& Mileva, 2011). The Mauchly sphericity test will be used to check homogeneity of covariance for all ANOVA analyses; violations of the assumption of sphericity will be correct using the Greenhouse-Geisser adjustment. Where appropriate, the effect size (ƞ2) will also be calculated.
Study design
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| P-CHO supplement | Experimental | Dietary Supplement: P-CHO supplementThis group will drink the P-CHO supplement in the first trial and the fruit milk shake in the second. |
| Fruit Milk Sake | Experimental | Dietary Supplement: Fruit Milk ShakeThis group will drink the fruit milk shake in the first trial and the P-CHO supplement in the second. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- healthy and lactose tolerant
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| P-CHO supplementAlso: Available in a common local market.In the first trial, this group will drink a protein (P)-carbohydrate (CHO) supplement and in the second trial the fruit milk shake. | Dietary supplement | P-CHO supplement |
| Fruit Milk ShakeAlso: Strawberry, bananas, skimmed milkThe fruit content of the milk shake will be 100 g of strawberry and the amount of banana necessary to guaranty 0.8-1.2 g CHO • kg-1 BW • h-1. | Dietary supplement | Fruit Milk Sake |
Primary outcome
Maximal peak torque of the knee extensors muscles
Time frame: Up to 48 h
To monitor functional recovery
Creatine kinase
Time frame: Up to 48 h
To monitor muscle damage
Lactate dehydrogenase
Time frame: Up to 48 h
To monitor muscle damage
Interleukine-6
Time frame: Up to 48 h
To monitor the inflammatory process
Total antioxidant status
Time frame: Up to 48 h
To monitor oxidative stress
Delayed onset muscle soreness
Time frame: Up to 48 h
By a visual analogue scale, 10 cm in length. To monitor muscle soreness
Mid-thigh girth, Three other girths will be measured: 5, 15 and 25 cm above the superior border of the patella.
Time frame: Up to 48 h
To monitor the inflammatory process
Protein carbonyls
Time frame: Up to 48 h
To monitor oxidative stress
3 secondary outcomes
Percentage of body fat
Time frame: 1 week before the first trial
Food records
Time frame: 2 days before each trial
Physical activity records
Time frame: 2 days before each trial
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jan 2013.
- Background: PubMed 14619981Banerjee AK, Mandal A, Chanda D, Chakraborti S. Oxidant, antioxidant and physical exercise. Mol Cell Biochem. 2003 Nov;253(1-2):307-12. doi: 10.1023/a:1026032404105.
- Background: PubMed 17378947Battino M, Mezzetti B. Update on fruit antioxidant capacity: a key tool for Mediterranean diet. Public Health Nutr. 2006 Dec;9(8A):1099-103. doi: 10.1017/S1368980007668554.
- Background: PubMed 21116024Beelen M, Burke LM, Gibala MJ, van Loon L JC. Nutritional strategies to promote postexercise recovery. Int J Sport Nutr Exerc Metab. 2010 Dec;20(6):515-32. doi: 10.1123/ijsnem.20.6.515.
- Background: PubMed 8615356Ben-Amotz A, Levy Y. Bioavailability of a natural isomer mixture compared with synthetic all-trans beta-carotene in human serum. Am J Clin Nutr. 1996 May;63(5):729-34. doi: 10.1093/ajcn/63.5.729.
- Background: PubMed 11733293Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med. 2001 Dec;8(12):1153-7. doi: 10.1111/j.1553-2712.2001.tb01132.x.
- Background: PubMed 12730415Bos C, Metges CC, Gaudichon C, Petzke KJ, Pueyo ME, Morens C, Everwand J, Benamouzig R, Tome D. Postprandial kinetics of dietary amino acids are the main determinant of their metabolism after soy or milk protein ingestion in humans. J Nutr. 2003 May;133(5):1308-15. doi: 10.1093/jn/133.5.1308.
- Background: PubMed 21233776Bowtell JL, Sumners DP, Dyer A, Fox P, Mileva KN. Montmorency cherry juice reduces muscle damage caused by intensive strength exercise. Med Sci Sports Exerc. 2011 Aug;43(8):1544-51. doi: 10.1249/MSS.0b013e31820e5adc.
- Background: PubMed 20518645Brancaccio P, Lippi G, Maffulli N. Biochemical markers of muscular damage. Clin Chem Lab Med. 2010 Jun;48(6):757-67. doi: 10.1515/CCLM.2010.179.
- Background: PubMed 19808984Burke LM, Castell LM, Stear SJ. BJSM reviews: A-Z of supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 1. Br J Sports Med. 2009 Oct;43(10):728-9. doi: 10.1136/bjsm.2009.063941. No abstract available.
- Background: PubMed 19955167Burke LM, Castell LM, Stear SJ, Rogers PJ, Blomstrand E, Gurr S, Mitchell N, Stephens FB, Greenhaff PL. BJSM reviews: A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance Part 4. Br J Sports Med. 2009 Dec;43(14):1088-90. doi: 10.1136/bjsm.2009.068643. No abstract available.
- Background: PubMed 9625058Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem. 1998 Jun;44(6 Pt 1):1309-15.
- Background: PubMed 12617692Cheung K, Hume P, Maxwell L. Delayed onset muscle soreness : treatment strategies and performance factors. Sports Med. 2003;33(2):145-64. doi: 10.2165/00007256-200333020-00005.
- Web page of the institution that funds the individual Ph.D. grant (SFRH/BD/75276/2010)Link provided by the sponsor.
Related trials for Muscle Damage
Recruiting
Intrathecal Baclofen and Pediatric Dystonia
Dystonic Cerebral Palsy
Active, not recruiting
Local Vibration for Drooling in Children With Cerebral Palsy
Cerebral Palsy (CP)
Active, not recruitingPhase 4
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
Peripheral Arterial Disease
Recruiting
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
Cerebral Palsy, Muscular Dystrophy
Not yet recruiting
Effects of Manual Lymphatic Drainage and Pressotherapy on Muscle Recovery After Eccentric Exercise in Physically Active Young Adults
Young Athletes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
José Soares, PhD study director
Faculdade de Desporto, Universidade do Porto
Monica V. Sousa, BSc principal investigator
Faculdade de Desporto, Universidade do Porto
Vitor H Teixeira, PhD study chair
Faculdade de Ciências da Nutrição e Alimentação, Universidade do Porto
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing P-CHO supplement and Fruit Milk Shake in people with Muscle Damage and Inflammation, run by Universidade do Porto at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Jan 2013. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Maximal peak torque of the knee extensors muscles (time frame: Up to 48 h). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01555775, which also lists 44 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2013.